Clinical Trials in Illinois

Showing 8261-8280 of 19,692 trials

Safety and Performance of Journey II XR Total Knee System

NCT03798847

The objective of this study is to estimate the safety and performance of Journey II XR TKS based on retrospective data.

Smith & Nephew, Inc.683 participantsStarted Nov 2018

Phoenix, Arizona, United States • Aurora, Illinois, United States • Port Huron, Michigan, United States +9 more locations

COMPLETEDPhase 3114 miles

Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.

NCT03619213

This is an international, multicentre, parallel-group, event-driven, randomised, double-blind, placebo-controlled study in HFpEF patients, evaluating the effect of dapagliflozin 10 mg versus placebo, given once daily in addition to background regional standard of care therapy, including treatments to control co-morbidities, in reducing the composite of CV death or heart failure events.

Heart Failure With Preserved Ejection Fraction

AstraZeneca6,263 participantsStarted Aug 2018

Fairhope, Alabama, United States • Mobile, Alabama, United States • Sheffield, Alabama, United States +345 more locations

Safety and Performance of Journey II XR Total Knee System

Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.

Find Trials by Condition in Illinois

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors

PDGeneration: Mapping the Future of Parkinson's Disease

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)

A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma

Simple Bone Cysts in Kids

Relapse Prevention Study in Patients With Schizophrenia

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)

A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness.

A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)

Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

A Trial of NT-I7 in COVID-19 (SPESELPIS)

Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology to Evaluate Overall Visual Acuity.

Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients

Noninvasive Biomarkers of Metabolic Liver Disease 1.1

A Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor in Participants With Cystic Fibrosis (CF)